CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 675 of 813 entries

View as:

Optimal Duration of Olanzapine Add-on Therapy in Major Depression

Phase: N/A Priority: Normal

NCT ID: NCT00568672 Org: User:

Start: 10/31/07 End: 04/30/08 Due: 04/30/09

Berlin PRehospital Or Usual Delivery of Acute Stroke Care 2.0 (B_PROUD 2.0)

Phase: N/A Priority: Normal

NCT ID: NCT03931616 Org: User:

Start: 05/09/19 End: 09/28/23 Due: 09/28/24

Protective Nerve Stimulation in Regional Anesthesia

Phase: N/A Priority: Normal

NCT ID: NCT03291691 Org: User:

Start: 09/20/17 End: 12/31/23 Due: 12/31/24

Feasibility of an Extended Test Battery and Influencing Factors for Detecting Frailty

Phase: N/A Priority: Normal

NCT ID: NCT04190329 Org: User:

Start: 12/18/19 End: 07/20/20 Due: 07/20/21

Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.

Phase: N/A Priority: Normal

NCT ID: NCT05824117 Org: User:

Start: 10/18/22 End: 03/31/25 Due: 03/31/26

Regional Cerebral Oxygen Saturation Under General Anesthesia A Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02101242 Org: User:

Start: 05/11/14 End: 09/17/14 Due: 09/17/15

Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)

Phase: N/A Priority: Normal

NCT ID: NCT02242721 Org: User:

Start: 10/31/14 End: 01/31/16 Due: 01/31/17

Reduction of Blood Recirculation in Veno-Venous ECMO

Phase: N/A Priority: Normal

NCT ID: NCT04754854 Org: User:

Start: 11/20/20 End: 10/31/26 Due: 10/31/27

Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal

NCT ID: NCT05541874 Org: User:

Start: 12/31/25 End: 05/11/26 Due: 05/11/27

Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome

Phase: N/A Priority: Normal

NCT ID: NCT05383963 Org: User:

Start: 07/15/22 End: 12/31/27 Due: 12/31/28

Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis

Phase: N/A Priority: Normal

NCT ID: NCT04158661 Org: User:

Start: 04/20/20 End: 06/30/22 Due: 06/30/23

Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years

Phase: N/A Priority: Normal

NCT ID: NCT02481999 Org: User:

Start: 09/08/15 End: 05/24/17 Due: 05/24/18

Prospective Evaluation of Frailty in Patients with Head and Neck Tumors Before Curative Intended Therapy

Phase: N/A Priority: Normal

NCT ID: NCT06638216 Org: User:

Start: 10/07/24 End: 12/31/25 Due: 12/31/26

3D Analysis of Peri-implant Soft Tissue with Two Different Connection Types

Phase: N/A Priority: Normal

NCT ID: NCT06627023 Org: User:

Start: 06/30/20 End: 01/12/24 Due: 01/12/25

Psychotherapeutic Augmentation of Brain Stimulation Effects

Phase: N/A Priority: Normal

NCT ID: NCT04159285 Org: User:

Start: 01/05/19 End: 06/15/21 Due: 06/15/22

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

Phase: N/A Priority: Normal

NCT ID: NCT04359147 Org: User:

Start: 11/01/19 End: 12/22/21 Due: 12/22/22

Emotional Competence and Compassion Online-Training

Phase: N/A Priority: Normal

NCT ID: NCT03789929 Org: User:

Start: 01/01/19 End: 07/31/20 Due: 07/31/21

Predicting Cognition After DBS for Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT03982953 Org: User:

Start: 06/12/19 End: 08/10/22 Due: 08/10/23

Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients

Phase: N/A Priority: Normal

NCT ID: NCT03097146 Org: User:

Start: 04/11/17 End: 03/01/21 Due: 03/01/22

An Exploratory Clinical Study on Autophagy During Fasting

Phase: N/A Priority: Normal

NCT ID: NCT04739852 Org: User:

Start: 02/01/21 End: 07/01/25 Due: 07/01/26

Transcranial Galvanic Stimulation After Stroke

Phase: N/A Priority: Normal

NCT ID: NCT00407667 Org: User:

Start: 12/31/06 End: 12/31/09 Due: 12/31/10

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT01413243 Org: User:

Start: 09/30/12 End: 06/30/17 Due: 06/30/18

Joint Line Reconstruction in Navigated Total Knee Arthroplasty Revision

Phase: N/A Priority: Normal

NCT ID: NCT01601756 Org: User:

Start: 09/30/11 End: 12/31/12 Due: 12/31/13

Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care.

Phase: N/A Priority: Normal

NCT ID: NCT01225133 Org: User:

Start: 10/31/10 End: 03/31/15 Due: 03/31/16

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Phase: N/A Priority: Normal

NCT ID: NCT01458548 Org: User:

Start: 12/31/02 End: 10/31/11 Due: 10/31/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Optimal Duration of Olanzapine Add-on Therapy in Major Depression	NCT00568672	Charite University, Berlin, Germany	user2@example.com	None	2007-10-31	2008-04-30	2009-04-30	-	-	2025-07-14
Berlin PRehospital Or Usual Delivery of Acute Stroke Care 2.0 (B_PROUD 2.0)	NCT03931616	Charite University, Berlin, Germany	user2@example.com	None	2019-05-09	2023-09-28	2024-09-28	-	-	2025-07-14
Protective Nerve Stimulation in Regional Anesthesia	NCT03291691	Charite University, Berlin, Germany	user2@example.com	None	2017-09-20	2023-12-31	2024-12-31	-	-	2025-07-14
Feasibility of an Extended Test Battery and Influencing Factors for Detecting Frailty	NCT04190329	Charite University, Berlin, Germany	user2@example.com	None	2019-12-18	2020-07-20	2021-07-20	-	-	2025-07-14
Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.	NCT05824117	Charite University, Berlin, Germany	user2@example.com	None	2022-10-18	2025-03-31	2026-03-31	-	-	2025-07-14
Regional Cerebral Oxygen Saturation Under General Anesthesia A Pilot Study	NCT02101242	Charite University, Berlin, Germany	user2@example.com	None	2014-05-11	2014-09-17	2015-09-17	-	-	2025-07-14
Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)	NCT02242721	Charite University, Berlin, Germany	user2@example.com	None	2014-10-31	2016-01-31	2017-01-31	-	-	2025-07-14
Reduction of Blood Recirculation in Veno-Venous ECMO	NCT04754854	Charite University, Berlin, Germany	user2@example.com	None	2020-11-20	2026-10-31	2027-10-31	-	-	2025-07-14
Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer	NCT05541874	Charite University, Berlin, Germany	user2@example.com	None	2025-12-31	2026-05-11	2027-05-11	-	-	2025-07-14
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome	NCT05383963	Charite University, Berlin, Germany	user2@example.com	None	2022-07-15	2027-12-31	2028-12-31	-	-	2025-07-14
Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis	NCT04158661	Charite University, Berlin, Germany	user2@example.com	None	2020-04-20	2022-06-30	2023-06-30	-	-	2025-07-14
Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years	NCT02481999	Charite University, Berlin, Germany	user2@example.com	None	2015-09-08	2017-05-24	2018-05-24	-	-	2025-07-14
Prospective Evaluation of Frailty in Patients with Head and Neck Tumors Before Curative Intended Therapy	NCT06638216	Charite University, Berlin, Germany	user2@example.com	None	2024-10-07	2025-12-31	2026-12-31	-	-	2025-07-14
3D Analysis of Peri-implant Soft Tissue with Two Different Connection Types	NCT06627023	Charite University, Berlin, Germany	user2@example.com	None	2020-06-30	2024-01-12	2025-01-12	-	-	2025-07-14
Psychotherapeutic Augmentation of Brain Stimulation Effects	NCT04159285	Charite University, Berlin, Germany	user2@example.com	None	2019-01-05	2021-06-15	2022-06-15	-	-	2025-07-14
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat	NCT04359147	Charite University, Berlin, Germany	user2@example.com	None	2019-11-01	2021-12-22	2022-12-22	-	-	2025-07-14
Emotional Competence and Compassion Online-Training	NCT03789929	Charite University, Berlin, Germany	user2@example.com	None	2019-01-01	2020-07-31	2021-07-31	-	-	2025-07-14
Predicting Cognition After DBS for Parkinson's Disease	NCT03982953	Charite University, Berlin, Germany	user2@example.com	None	2019-06-12	2022-08-10	2023-08-10	-	-	2025-07-14
Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients	NCT03097146	Charite University, Berlin, Germany	user2@example.com	None	2017-04-11	2021-03-01	2022-03-01	-	-	2025-07-14
An Exploratory Clinical Study on Autophagy During Fasting	NCT04739852	Charite University, Berlin, Germany	user2@example.com	None	2021-02-01	2025-07-01	2026-07-01	-	-	2025-07-14
Transcranial Galvanic Stimulation After Stroke	NCT00407667	Charite University, Berlin, Germany	user2@example.com	None	2006-12-31	2009-12-31	2010-12-31	-	-	2025-07-14
Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome	NCT01413243	Charite University, Berlin, Germany	user2@example.com	None	2012-09-30	2017-06-30	2018-06-30	-	-	2025-07-14
Joint Line Reconstruction in Navigated Total Knee Arthroplasty Revision	NCT01601756	Charite University, Berlin, Germany	user2@example.com	None	2011-09-30	2012-12-31	2013-12-31	-	-	2025-07-14
Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care.	NCT01225133	Charite University, Berlin, Germany	user2@example.com	None	2010-10-31	2015-03-31	2016-03-31	-	-	2025-07-14
Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)	NCT01458548	Charite University, Berlin, Germany	user2@example.com	None	2002-12-31	2011-10-31	2012-10-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance